Google
Trusted Resources: News & Events
Latest announcements and gatherings
Hospitals See No Link Between US Opioid Crisis and Patients’ Use of Treatment, Study Reports
The U.S. opioid epidemic is not linked to higher in-hospital mortality in patients with sickle cell disease (SCD), according to a national study.
The study came about due to the pronounced increase in opioid-related overdoses and deaths in the U.S. that has been reported since 2000. Its researchers did find increased hospitalization rates in young adult and elderly SCD patients, but not in deaths linked to opioids used to control disease-related pain.
“Opioid Use Is NOT Associated with in-Hospital Mortality Among Patients with Sickle CELL Disease in the United States: Findings from the National Inpatient Sample,” was recently presented at the 60th American Society of Hematology (ASH) Annual Meeting, in San Diego.
+myBinderRelated Content
-
Citizens for Quality Sickle Cell CareThe New England Sickle Cell Institute at...
-
Chronic Opioid Use Pattern in Adult Patients with Sickle Cell DiseaseBackground: Pain, the hallmark complicat...
-
University of Pittsburgh Medical Center, Heart and Vascular InstituteThe Vascular Medicine Institute at the U...
-
Associations of Prolonged QTc in Sickle Cell DiseaseSudden death is a leading cause of morta...
-
The ‘Voice of Lagos’ is silent: Entertainer Tosyn Bucknor dies at 37Nigerians are paying tribute t...
-
Finding the right sickle cell disease care teamChandra Wallace does not remember a time...
-
Long-term opioids may not be best pain management option for all sickle cell patientsSmall study shows some on opioids report...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.